Clinical trials
Phase 1/2 Mesothelioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 10 |
| Recruiting | 10 |
| Unknown status | 4 |
| Withdrawn | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Biosciences International Sàrl | 3 |
| National Cancer Institute (NCI) | 3 |
| Memorial Sloan Kettering Cancer Center | 2 |
| TCR2 Therapeutics | 2 |
| Tango Therapeutics, Inc. | 2 |
| A2 Biotherapeutics Inc. | 1 |
| Baylor College of Medicine | 1 |
| Beijing Biotech | 1 |
| Case Comprehensive Cancer Center | 1 |
| Deciphera Pharmaceuticals, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma | 44 |
| Carcinoma, Non-Small-Cell Lung | 17 |
| Ovarian Neoplasms | 14 |
| Stomach Neoplasms | 12 |
| Mesothelioma, Malignant | 10 |
| Pancreatic Neoplasms | 10 |
| Esophageal Neoplasms | 9 |
| Melanoma | 9 |
| Colorectal Neoplasms | 8 |
| Breast Neoplasms | 7 |
Trials
Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.